Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteprognomix.com
CategoryBioTech
Phone514-529-9757
Employees

Offices

Canada
4101, rue Molson, bureau 201
Montreal (Quebec)
H1Y 3L1, CAN

Funding

TOTAL $4.1M
FUNDING TOTAL $4.1M
Venture Round, 3/2007
BDC Venture Capital
Picchio Pharma
$4.1M

Tags

Prognomix

Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.

Recent Milestones

  • Dollar
    Prognomix received $4.1M in Venture Round funding. (3/29/07)
    Posted 3/17/10 at 4:13am via bdc.ca

Videos

Screenshots

Prognomix screenshot
Above: Prognomix
Uploaded: 3/17/10

Sources

  1. Fonds Bio-Innovation, BDC Venture Capital and Picchio Pharma invest in Prognomix, a Montreal biotechnology firm, as part of a $4.1 million financing round (bdc.ca) [edit]
Edit This Page
Last Edited 3/17/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy